Li. Olbinskaya et al., THE IMPACT OF MOLSIDAMINE DRUGS ON CORONA RY AND MYOCARDIAL RESERVES IN CORONARY HEART-DISEASE PATIENTS WITH CIRCULATORY INSUFFICIENCY, Terapevticeskij arhiv, 66(8), 1994, pp. 30-32
Molsidomine drugs corvation and sidnopharm were given as monotherapy t
o 95 coronary heart disease (CHD) patients with circulatory defects. P
ositive effects on coronary and myocardial reserves were reported in 7
0,8 and 58.3%, 68,4 and 56.8% of cases, respectively. Corvaton caused
side effects in 3.1%, sidnopharm in 12.5% of the patients. Corvaton is
more potent as regards hemo-dynamics, myocardial contractility and re
serves.